CVRx, Inc. (CVRX) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Minneapolis, MN, 미국. 현재 CEO는 Kevin Hykes.
CVRX 을(를) 보유 IPO 날짜 2021-06-30, 206 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $203.13M.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
